Team

P2 has assembled an executive team with strong backgrounds in technology, markets and financing. In addition the shareholder group and advisory board provide a solid platform to support growth.

Executive Team

Chairman – Rob Bettigole

  • Founder and Managing Partner of Elm Street Ventures
  • Board member/observer at a range of companies including Affomix Corporation, BioRelix, Inc., Samara Innovations, ShareGrove, Occam Pharma
  • B.S. in Engineering & Applied Science from Yale University; MPPM from the Yale School of Management

CEO – Neil Burns

    • 20 years surfactant experience in commercial, financial and general management
    • Managing Partner, Neil A. Burns LLC, investment and advisory firm.
    • Former CEO of Oxiteno USA, the US subsidiary of Ultrapar of Brazil
    • B.S. Chemistry, MBA (Wharton)


Chief Scientific Officer – Patrick Foley

  • PhD (ABD) Environmental Engineering, Yale University
  • B.S. Molecular Biology, University of Connecticut
  • Discovery Research, Pfizer (2004-2008)

Research Director – Matthew Dunn

  • Project Leader, Pfizer
  • Research Chemist, Inframat
  • M.Sc. Organic Chemistry, University of Connecticut

Share Holders

In addition to co-founders and key employees, P2′s Shareholders include:

Elm Street Ventures

  • An early stage investment fund based in New Haven, CT
  • Focused on Life Sciences, Cleantech
  • www.elmvc.com

Yale University